Brief: Cns Pharmaceuticals Announces FDA Approval Of IND Application For Its Brain Cancer Drug Candidate Berubicin

CNS Pharmaceuticals

17/12/2020 14:23

Dec 17 (Reuters) - CNS Pharmaceuticals Inc  CNSP.O :
    * CNS PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF IND
APPLICATION
FOR ITS BRAIN CANCER DRUG CANDIDATE BERUBICIN
    * CNS PHARMACEUTICALS INC -  WILL INITIATE ITS TRIAL DURING
Q1 OF
2021 TO INVESTIGATE EFFICACY OF BERUBICIN

Source text for Eikon:  ID:nPn1KGSZVa 
Further company coverage:  CNSP.O 

 ((Reuters.Briefs@thomsonreuters.com;))